-
The Louisiana Office of Public Health in New Orleans, LA, continues to face challenges with HIV/AIDS surveillance data three years post-Hurricane Katrina.
-
The next step that HIV clinicians should take in improving their patients' HIV treatment adherence is to match patients to the optimal adherence strategies for each person, an adherence expert and HIV researcher says.
-
The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection have been revised. The new version includes updated information on:
-
HIV physicians and AIDS activists are calling for major changes in funding and prevention in light of the recent news that the estimated annual HIV infection rate in the U.S. has been off by 40% for about 15 years.
-
-
Researchers have uncovered new evidence that strengthens the link between a host-cell gene called Apobec3 and the production of neutralizing antibodies to retroviruses.
-
Regardless of where we practice, increasingly we are confronted with patients who have been exposed to unusual diseases through travel. In a previous series of articles, we reviewed the diseases associated with travel, largely based on the geography. This article reviews infectious disease associated with travel by symptoms.
-
-
The Food and Drug Administration (FDA) has cleared for marketing a device made from a new form of natural rubber latex, guayule latex. The Yulex Patient Examination Glove, made by Maricopa, AZ-based Yulex, is derived from the guayule bush, a desert plant native to the southwestern United States.
-
The following information is excerpted with permission from the April 2008 issue of SAMBA Talks, published by the Society for Ambulatory Anesthesia:
